Gemcitabine Hydrochloride Powder
FDA Label NDC 62128-0383

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Evonik Corporation for the product Gemcitabine Hydrochloride (NDC 62128-0383). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding on each inner pail. (generic) produced material label, shipping label on outer drum., (generic) warehouse weight label, may 2022 warehouse kg label, warehouse kg elma dec2022, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

* Please review the disclaimer below.